Free tool
Oncology stocks
We cover 5 companies grouped under the Oncology theme. The median market value in the group is $707.84M. Across the group, the median move over the past trading day is +0.36%. Price change over the past year runs from −8.1% to +118.7% across the middle 80 percent of the group, with a median of +75.0%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
5 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| 6MK.DE | Merck & Co., Inc. | $379.64B | Mega cap | +91.49% |
| 0I3Q.L | Corcept Therapeutics Incorporated | $4.54B | Mid cap | +74.96% |
| 0SZI.L | Corbus Pharmaceuticals Holdings, Inc. | $707.84M | Small cap | +9.60% |
| 0LOV.L | Verastem, Inc. | $470.33M | Small cap | −19.93% |
| 0XOD.L | UroGen Pharma Ltd. | $347.24M | Small cap | +136.88% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.